loadpatents
name:-0.024179935455322
name:-0.010225057601929
name:-0.042577028274536
Stephan; Matthias Patent Filings

Stephan; Matthias

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stephan; Matthias.The latest application filed is for "constitutive expression of costimulatory ligands on adoptively transferred t lymphocytes".

Company Profile
3.14.24
  • Stephan; Matthias - Seattle WA
  • Stephan; Matthias - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Systems and methods to improve vaccine efficacy
Grant 11,440,945 - Stephan September 13, 2
2022-09-13
Constitutive Expression Of Costimulatory Ligands On Adoptively Transferred T Lymphocytes
App 20220016170 - Sadelain; Michel ;   et al.
2022-01-20
Methods And Compositions For Localized Agent Delivery
App 20210259968 - IRVINE; Darrell J. ;   et al.
2021-08-26
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
Grant 11,077,140 - Sadelain , et al. August 3, 2
2021-08-03
Nanoparticles For Gene Expression And Uses Thereof
App 20210128485 - Stephan; Matthias
2021-05-06
Altering Inflammatory States Of Immune Cells In Vivo By Modulating Cellular Activation States
App 20210046156 - Stephan; Matthias
2021-02-18
Compositions And Methods For Delivery Of Immune Cells To Treat Un-resectable Or Non-resected Tumor Cells And Tumor Relapse
App 20210015863 - Stephan; Matthias
2021-01-21
Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
Grant 10,806,756 - Stephan October 20, 2
2020-10-20
Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
Grant 10,702,551 - Stephan
2020-07-07
Systems And Methods To Improve Vaccine Efficacy
App 20200123219 - STEPHAN; Matthias
2020-04-23
Scaffolds To Treat Solid Tumor Cells And Escape Variants
App 20190336532 - Stephan; Matthias ;   et al.
2019-11-07
Compositions And Methods To Modify Cells For Therapeutic Objectives
App 20190330373 - Stephan; Matthias
2019-10-31
Compositions and methods to modify cells for therapeutic objectives
Grant 10,392,446 - Stephan A
2019-08-27
Compositions And Methods To Program Therapeutic Cells Using Targeted Nucleic Acid Nanocarriers
App 20190111153 - Stephan; Matthias ;   et al.
2019-04-18
Compositions And Methods For Delivery Of Immune Cells To Treat Un-resectable Or Non-resected Tumor Cells And Tumor Relapse
App 20190054121 - Stephan; Matthias
2019-02-21
Compositions And Methods For Delivery Of Immune Cells To Treat Un-resectable Or Non-resected Tumor Cells And Tumor Relapse
App 20190046572 - Stephan; Matthias
2019-02-14
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
Grant 10,188,749 - Stephan , et al. Ja
2019-01-29
Constitutive Expression Of Costimulatory Ligands On Adoptively Transferred T Lymphocytes
App 20190000881 - Sadelain; Michel ;   et al.
2019-01-03
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
Grant 10,117,897 - Sadelain , et al. November 6, 2
2018-11-06
Methods And Compositions For Localized Agent Delivery
App 20180110733 - IRVINE; Darrell J. ;   et al.
2018-04-26
Compositions And Methods To Modify Cells For Therapeutic Objectives
App 20180030153 - Stephan; Matthias
2018-02-01
Compositions And Methods To Program Therapeutic Cells Using Targeted Nucleic Acid Nanocarriers
App 20170296676 - Stephan; Matthias ;   et al.
2017-10-19
Methods And Compositions For Localized Agent Delivery
App 20160256386 - IRVINE; Darrell J. ;   et al.
2016-09-08
Methods and compositions for localized agent delivery
Grant 9,393,199 - Irvine , et al. July 19, 2
2016-07-19
Compositions And Methods To Modify Cells For Therapeutic Objectives
App 20160145348 - Stephan; Matthias
2016-05-26
Methods and compositions for localized agent delivery
Grant 9,283,184 - Irvine , et al. March 15, 2
2016-03-15
Constitutive Expression Of Costimulatory Ligands On Adoptively Transferred T Lymphocytes
App 20160008398 - Sadelain; Michel ;   et al.
2016-01-14
Compositions And Methods For Delivery Of Immune Cells To Treat Un-resectable Or Non-resected Tumor Cells And Tumor Relapse
App 20160008399 - STEPHAN; MATTHIAS
2016-01-14
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
Grant 9,220,728 - Sadelain , et al. December 29, 2
2015-12-29
Methods And Compositions For Localized Agent Delivery
App 20140017170 - Irvine; Darrell J. ;   et al.
2014-01-16
Constitutive Expression Of Costimulatory Ligands On Adoptively Transferred T Lymphocytes
App 20130121960 - Sadelain; Michel ;   et al.
2013-05-16
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
Grant 8,389,282 - Sadelain , et al. March 5, 2
2013-03-05
Methods And Compositions For Localized Agent Delivery
App 20110293705 - Irvine; Darrell J. ;   et al.
2011-12-01
Constitutive Expression Of Costimulatory Ligands On Adoptively Transferred T Lymphocytes
App 20100178276 - Sadelain; Michel ;   et al.
2010-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed